Aptose Biosciences
APTO
#10464
Rank
A$6.57 M
Marketcap
A$2.58
Share price
0.00%
Change (1 day)
724.13%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -A$31.68 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$37.99 Million, an increase over its 2023 earnings that were of -A$78.86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$31.68 Million-16.62%
2024 -A$37.99 Million-51.82%
2023 -A$78.86 Million22.9%
2022 -A$64.17 Million-34.91%
2021 -A$98.57 Million17.36%
2020 -A$84 Million107.65%
2019 -A$40.45 Million-7.73%
2018 -A$43.84 Million160.68%
2017 -A$16.82 Million-20.27%
2016 -A$21.1 Million28.71%
2015 -A$16.39 Million
2013 -A$9.29 Million
2010 -A$7.92 Million-8.31%
2009 -A$8.63 Million
2006 -A$16 Million-156.93%
2005 A$28.1 M-185.16%
2004 -A$33 Million458.58%
2003 -A$5.91 Million-63.66%
2002 -A$16.26 Million-8.04%
2001 -A$17.68 Million16.73%
2000 -A$15.15 Million294.99%
1999 -A$3.84 Million-6.51%
1998 -A$4.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-A$51.25 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-A$86.71 Million 175.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-A$94.56 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA